Upregulation of lipopolysaccharide-induced interleukin-10 by prostaglandin A1 in mouse peritoneal macrophages

Journal of Microbiology and Biotechnology

Volumn 18, Issue 6, 2008, Pages 1170-1178

  Kim, Hyo Young ^a   Kim, Jae Ryong ^a   Kim, Hee Sun ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

IL 10; Macrophage; PGA1

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN A1; STRESS ACTIVATED PROTEIN KINASE; 15 DEOXY DELTA(12,14) PROSTAGLANDIN J2; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J2; DRUG DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROSTAGLANDIN A; PROSTAGLANDIN D2;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; RNA SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PPAR GAMMA; PROSTAGLANDIN D2; PROSTAGLANDINS A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 53149114535     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Alleva, D. G., E. B. Johnson, F. M. Lio, S. A. Boehme, P. J. Conlon, and P. D. Crowe. 2002. Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-γ: Counter-regulatory activity by IFN-γ. J. Leukoc. Biol. 71: 677-685.
2. 2 inhibits IL-10 and IL-12 production by macrophages. Biochem. Biophys. Res. Commun. 283: 344-346.
3. Bureau, F., C. Desmet, D. Melotte, F. Jaspar, C. Volanti, A. Vanderplasschen, P. P. Pastoret, J. Piette, and P. Lekeux. 2002. A proinflammatory role for the cyclopentenone prostaglandins at low micromolar concentrations: Oxidative stress-induced extracellular signal-regulated kinase activation without NF-kappa B inhibition. J. Immunol. 168: 5318-5325.
4. Chinetti, G., J. C. Fruchart, and B. Staels. 2000. Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 49: 497-505.
5. Clark, R. B. 2002. The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 71: 388-400.
6. Cunard, R., M. Ricote, D. DiCampli, D. C. Archer, D. A. Kahn, C. K. Glass, C. J. Kelly, and M. Ricote. 2002. Regulation of cytokine expression by ligands of peroxisome proliferator activated receptors. J. Immunol. 168: 2795-2802.
7. 2 attenuates the development of acute and chronic inflammation. Mol. Pharmacol. 61: 997-1007.
8. Erl, W., C. Weber, A. Zernecke, J. Neuzil, C. A. Vosseler, H. J. Kim, and P. C. Weber. 2004. Cyclopentenone prostaglandins induce endothelial cell apoptosis independent of the peroxisome proliferator-activated receptor-γ. Eur. J. Immunol. 34: 241-250.
9. 2) in human THP-1 macrophages. Atherosclerosis 160: 11-20.
10. 2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J. Immunol. 168: 1372-1379.
11. Jiang, C., A. T. Ting, and B. Seed. 1998. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 391: 82-86.
12. Jostarndt, K., T. Rubic, H. Kuhn, M. W. Anthosen, L. Andera, N. Gellert, et al. 2004. Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-γ-dependent way. Biochem. Pharmacol. 67: 841-854.
13. 2 and a peroxisome proliferator-activated receptor γ agonist on macrophage activation. J. Leukoc. Biol. 69: 631-638.
14. 2 in mouse peritoneal macrophages. Immunol. Cell Biol. 83: 286-293.
15. 2 in mouse peritoneal macrophages. Immunol. Cell Biol. 85: 60-67.
16. Kim, H. Y., J. R. Kim, and H. S. Kim. 2006. Synergistic effect of interleukin-10 on the expression of lipopolysaccharide-induced IP-10 (CXCL-10) mRNA in mouse peritoneal macrophges. J. Microbiol. Biotechnol. 16: 1605-1612.
17. Kim, J. E., H. J. Hur, K. W. Lee, and H. J. Lee. 2007. Antiinflammatory effects of recombinant arginine deiminase originating from Lactococcus lactis ssp. lactis ATCC 7962. J. Microbiol. Biotechnol. 17: 1491-1497.
18. Lee, D. E., H. Y. Kim, I. H. Song, S. K. Kim, J. H. Seul, and H. S. Kim. 2004. Effect of leptin on the expression of lipopolysaccharide-induced chemokine KC mRNA in the mouse peritoneal macrophages. J. Microbiol. Biotechnol. 14: 722-729.
19. Marx, N., F. Mach, A. Sauty, J. H. Leung, M. N. Sarafi, R. M. Randohoff, P. Libby, J. Plutzky, and A. D. Luster. 2000. Peroxisome proliferator-activated receptor-γ activators inhibit IFN-γ-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J. Immunol. 164: 6503-6508.
20. Masamune, A., K. Kikuta, M. Satoh, Y. Sakai, A. Satoh, and T. Shimosegawa. 2002. Ligands of peroxisome proliferator-activated receptor-γ block activation of pancreatic stellate cells. J. Biol. Chem. 277: 141-147.
21. Meade, E. A., T. M. Mcintyre, G. A. Zimmerman, and S. M. Prescott. 1999. Peroxisome proliferators enhance cyclooxygenase-2 expression in epithelial cells. J. Biol. Chem. 274: 8328-8334.
22. 2 inhibition of mesangial cell iNOS expression. Clin. Immunol. 3: 337-345.
23. Ricote, M., A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass. 1998. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391: 79-82.
24. Ricote, M., J. T. Huang, J. S. Welch, and C. K. Glass. 1999. The peroxisome proliferator-activated receptorγ (PPARγ) as a regulator of monocyte/macrophage function. J. Leukoc. Biol. 66: 733-739.
25. Rosen, E. D., C. J. Walkey, P. Puigserver, and B. M. Spiegelman. 2000. Transcriptional regulation of adipogenesis. Genes Dev. 14: 1293-1307.
26. Rossi, A., G. Elia, and M. G. Santoro. 1997. Inhibition of nuclear factor κB by prostaglandin A1: An effect associated with heat shock transcription factor activation. Proc. Natl. Acad. Sci. USA 94: 746-750.
27. 2 inhibits IL-1β-induced cyclooxygenase-2 expression in mesangial cells. Kidney Int. 61: 1957-1967.
28. Simonin, M. A., K. Bordji, S. Boyault, A. Bianchi, E. Gouze, P. Becume, M. Dauca, P. Netter, and B. Terlain. 2002. PPAR-γ ligands modulate effects of LPS in stimulated rat synovial fibroblasts. Am. J. Physiol. Cell Physiol. 282: 125-133.
29. Straus, D. S. and C. K. Glass. 2001. Cyclopentenone prostaglandins: New insight on biological activities and cellular targets. Med. Res. Rev. 3: 185-210.
30. 2 inhibits multiple steps in the NF-κB signaling pathway. Proc. Natl. Acad. Sci. USA 97: 4844-4849.
31. Wayman, N. S., Y. Hattori, M. C. McDonald, H. Mota-Filipe, S. Cuzzocrea, B. Pisano, P. K. Chatterjee, and C. Thiemermann. 2002. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J. 16: 1027-1040.
32. Wilmer, W. A., C. Dixon, L. Lu, T. Hilbelink, and B. H. Rovin. 2001. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARγ. Biochem. Biophys. Res. Commun. 281: 57-62.
33. 2. J. Immunol. 166: 7104-7111.
34. 2 inhibits astrocyte IL-1 signaling: Inhibition of NF-kappaB and MAP kinase pathways and suppression of cytokine and chemokine expression. J. Neuroimmunol. 153: 132-142.